Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 79-83

  Gordon, B ^a   Lyden, E ^b   Lynch, J ^b   Tarantolo, S ^a   Pavletic, Z S ^a   Bishop, M ^a   Reed, E ^a   Kessinger, A ^a   Haire, W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CNS dysfunction; Multiple organ dysfunction; Stem cell transplant

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ALLOGRAFT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE COURSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LIVER DYSFUNCTION; LIVER VEIN OBSTRUCTION; LUNG DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RISK; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

EID: 0033951663     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702082     Document Type: Article

References (25)

1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985; 202: 685-693.
2. Faist EN, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983; 9: 775-787.
3. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple-organ failure. Arch Surg 1985; 20: 1109-1115.
4. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Int Med 1993; 118: 255-267.
5. Haire WD, Ruby EI, Gordon BG et al. Multiple organ dysfunction syndrome in bone marrow transplantation. J Am Med Assoc 1995; 274: 1289-1295.
6. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
7. McDonald GB, Sharma P, Matthews DE et al. Veno-occlusive disease of the liver after bone marrow transplantation. Diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116-122.
8. Jones RJ, Lee KS, Beschorner WE et al. Venocclusive disease of the liver following bone marrow transplantation. Transpl 1987; 44: 778-783.
9. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurologic complications of bone marrow transplantation in childhood. Ann Neurol 1984; 16: 569-576.
10. Patchell RA, White CL, Clark AW et al. Neurologic complications of bone marrow transplantation. Neurol 1985; 35: 300-306.
11. Graus F, Saiz A, Sierra J et al. Neurologic complications of autologous and allogeneic hone marrow transplantation in patients with leukemia: a comparative study. Neurol 1996; 46: 1004-1009.
12. Antonini G, Ceschin V, Morino S et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurol 1998; 50: 1441-1445.
13. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurol 1994; 44: 681-684.
14. Furlong TG, Gallucci BB. Patterns of occurrence and clinical presentation of neurological complications in hone marrow transplant patients. Cancer Res 1994; 17: 27-36.
15. Anthony RC, LeResche L, Niaz U et al. Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med 1982; 12: 397-408.
16. Faioni EM, Krachmalnicoff A, Bearman SI et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 1993; 81: 3458-3462.
17. Gordon BG, Tarantolo SR, Ruby EI et al. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1998; 22: 999-1003.
18. Rio B, Andreu G, Nicod A et al. Thrombocytopenia in veno-occlusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773-1776.
19. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome. Ann Int Med 1996; 125: 680-687.
20. Haire WD. The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation. Semin Thromb Hemost 1999; 25: 223-237.
21. Haire WD, Stephens LC, Ruby EI. Systemic inflammatory response syndrome (SIRS), sepsis and organ dysfunction in hone marrow transplantation (BMT). Blood 1996; 88 (Suppl. 1): 255b (3748).
22. Dickniete G, Paques EP. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis. Thromb Haemost 1993: 69: 98-102.
23. Phillips TF, Staricco A, Assarian GS et al. Antithrombin administration protects from experimental DIC. Blood 1983; 62 (Suppl. 1): 308a.
24. Haire WD, Stephens LC, Ruby EI. Antithrombin III (AT3) treatment of organ dysfunction during bone marrow transplantation (BMT): results of a pilot study. Blood 1996; 88 (Suppl. 1): 458a.
25. Morris J, Harris RE, Hashmi R et al. Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 871-878.